Ortho Evra Contraceptive Patch Lawyers 1-800-LAW-INFO

Parker & Waichman, LLP is the Leader in ORTHO EVRA Litigation.
Below are recent press releases concerning our Ortho Evra Litigation Activities.

Parker & Waichman, LLP, Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Victim of Ortho Evra Birth Control Patch

23-Year-Old Victim Suffered Multiple Pulmonary Embolisms after Using Ortho Evra for 10 Months

NEW YORK, Nov. 8, 2015 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 23-year-old woman who suffered a massive pulmonary embolism in her right main pulmonary artery and a second pulmonary embolism in her left pulmonary artery after using the Ortho Evra contraceptive patch for ten months. As a result, the plaintiff underwent a pulmonary thromboendarterectomy, which resulted in the dissection of chronic thromboembolic material from both lower lobe pulmonary arteries. The suit was filed on November 3, 2015 in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra please visit www.orthopatchlawsuit.com.

Parker & Waichman, LLP Comments on Published Study Underscoring Risks of Ortho Evra Birth Control Patch

NEW YORK, Sept. 26, 2015 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com), a leading pharmaceutical liability law firm representing victims who have suffered side effects associated with the Ortho Evra Birth Control Patch, believes that a recent medical study, published in the journal Contraception, clearly illustrates the increased risks of Ortho Evra when compared with other forms of birth control. The study compares ethinylestradiol (EE) pharmacokinetics in three types of hormonal contraceptives: the transdermal patch, the vaginal ring, and an oral contraceptive. The study confirms that, "Of the three contraceptive methods, exposure to EE was highest for the patch group." It is believed that prolonged exposure to high levels of estrogen may be associated with increased risk of adverse effects, including blood clots, pulmonary emboli, and strokes. Ortho Evra is an adhesive, transdermal birth control patch manufactured by Ortho-McNeil, a division of Johnson & Johnson (NYSE: JNJ). For more information on Ortho Evra please visit www.orthopatchlawsuit.com or www.yourlawyer.com.

Parker & Waichman, LLP, Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Victim of Ortho Evra Birth Control Patch

37 Year Old Victim Suffered Pulmonary Embolism after Using Ortho Evra for 7 Months

NEW YORK, Sept. 12, 2015 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 37 year old woman who suffered a pulmonary embolism after using the Ortho Evra contraceptive patch for seven months. The suit was filed on September 2, 2015 in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho please visit www.orthopatchlawsuit.com .

Parker & Waichman, LLP Files Application Requesting Designation of Ortho Evra Litigation as a Mass Tort for Central Management in Superior Court of New Jersey -- JNJ

NEW YORK, Sept. 1, 2015 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has formally requested that pharmaceutical liability lawsuits involving the Ortho Evra transdermal birth control patch that have been filed or that will be filed in the Superior Courts of the State of New Jersey be designated as a Mass Tort for centralized management pursuant to R.4:38A. Ortho Evra has been associated with potentially fatal side effects including strokes, pulmonary emboli, blood clots, deep vein thrombosis and heart attacks. Ortho Evra is manufactured by Ortho McNeil, a subsidiary of Johnson & Johnson (NYSE:JNJ), which is based in New Jersey. For more information on Ortho Evra please visit http://www.orthopatchlawsuit.com.

Parker & Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Victim of Ortho Evra Birth Control Patch -- JNJ

Thirty-Year-Old Victim Suffered Two Blood Clots in Brain after Using Ortho Evra for Seven Months

NEW YORK, July 29, 2015 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 30-year-old wife and mother of four who developed life-threatening blood clots after using the Ortho Evra contraceptive patch. The victim was admitted into the intensive care unit in July 2003 due to a severe headache, blurry vision, nausea and vomiting. Tests determined the cause to be a posterior-superior sagittal sinus thrombosis with associated subarachnoid hemorrhage. The suit was filed on July 26, 2015, in the Middlesex County Court House in New Brunswick, New Jersey. For more information on Ortho Evra side effects and to request a free case evaluation please visit www.orthopatchlawsuit.com.

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Date you started using Ortho Evra (mm-yyyy):

Date you stopped using Ortho Evra (mm-yyyy):

Did you experience any of the following complications during or after using Ortho Evra?





Do you smoke?

Please further describe side effects:

Other information:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.